Skip to main content
. 2014 Dec 4;16(12):e265. doi: 10.2196/jmir.3643

Table 3.

Dose-response relationship of Δ minutes spent in moderate-to-vigorous physical activity with endpoints.a

Characteristics Intervention group P for trend

Low (n=36) Middle (n=36) High (n=36)
Baseline moderate-to-vigorous activity




Mean (SD) 22.5 (17.9) 17.3 (16.5) 19.0 (14.9) .38

Range 2.4 to 87.2 0.8 to 92.0 2.4 to 62.4
Δ minutes moderate-to-vigorous activity




Mean (SD) –6.75 (8.20) 5.91 (3.56) 34.27 (21.52)

Range –25.8 to 1.60 1.70 to 14.2 15.8 to 117.6
Successful participants, n 11 12 26 .001
Clinical parameters (mean Δ, SE)




Weight (kg) –0.93 (0.35) –0.64 (0.44) –2.85 (0.51) .004

BMI (kg/m2) –0.34 (0.12) –0.23 (0.15) –0.88 (0.17) .02

Waist circumference (cm) –1.58 (0.52) –1.92 (0.67) –3.69 (0.72) .03

Fat percentage –0.46 (0.48) –0.44 (0.35) –0.94 (0.43) .43
Cardiovascular disease risk (mean Δ, SE)




Framingham risk score (%) 0.43 (0.46) –0.78 (0.52) –1.28 (0.76) .045
Biochemistry (mean Δ, SE)




Glucose (mmol/L) –0.23 (0.10) –0.15 (0.09) –0.21 (0.07) .94

Ln insulin (mU/L) –0.14 (0.07) –0.06 (0.08) –0.26 (0.08) .20

HbA1c (%) –0.04 (0.02) –0.03 (0.02) –0.07 (0.02) .20

Ln HOMA index –0.18 (0.08) –0.09 (0.08) –0.30 (0.08) .26

Total cholesterol (mmol/L) –0.29 (0.08) –0.10 (0.10) –0.40 (0.11) .63

HDL cholesterol (mmol/L) –0.10 (0.04) 0.01 (0.04) 0.05 (0.03) .007

Ln triglycerides (mmol/L) 0.003 (0.05) –0.06 (0.05) –0.22 (0.07) .02

LDL cholesterol (mmol/L) –0.19 (0.06) –0.09 (0.08) –0.27 (0.09) .61

Cholesterol/HDL ratio 0.006 (0.08) –0.15 (0.11) –0.48 (0.17) .02

Ln C-reactive protein (mg/L) –0.11 (0.10) –0.17 (0.13) –0.23 (0.17) .66

a P for trend was calculated with linear regression. P for trend was adjusted for sex and age, except for Framingham risk score for which age and sex are integrated.